351 related articles for article (PubMed ID: 12600898)
21. Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model.
Du H; Li P; Pan Y; Li W; Hou J; Chen H; Wang J; Tang H
Brain Res; 2010 Oct; 1357():1-8. PubMed ID: 20637183
[TBL] [Abstract][Full Text] [Related]
22. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes.
Tchaikovski V; Fellbrich G; Waltenberger J
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):322-8. PubMed ID: 18079407
[TBL] [Abstract][Full Text] [Related]
24. Effects of angiogenic growth factor combinations on retinal endothelial cells.
Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
[TBL] [Abstract][Full Text] [Related]
25. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells.
Mac Gabhann F; Popel AS
Am J Physiol Heart Circ Physiol; 2004 Jan; 286(1):H153-64. PubMed ID: 12714333
[TBL] [Abstract][Full Text] [Related]
26. Altered tumor vessel maturation and proliferation in placenta growth factor-producing tumors: potential relationship to post-therapy tumor angiogenesis and recurrence.
Taylor AP; Rodriguez M; Adams K; Goldenberg DM; Blumenthal RD
Int J Cancer; 2003 Jun; 105(2):158-64. PubMed ID: 12673673
[TBL] [Abstract][Full Text] [Related]
27. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
28. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.
Graziani G; Ruffini F; Tentori L; Scimeca M; Dorio AS; Atzori MG; Failla CM; Morea V; Bonanno E; D'Atri S; Lacal PM
Oncotarget; 2016 Nov; 7(45):72868-72885. PubMed ID: 27655684
[TBL] [Abstract][Full Text] [Related]
30. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.
Tjwa M; Luttun A; Autiero M; Carmeliet P
Cell Tissue Res; 2003 Oct; 314(1):5-14. PubMed ID: 13680354
[TBL] [Abstract][Full Text] [Related]
31. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
Taylor AP; Osorio L; Craig R; Raleigh JA; Ying Z; Goldenberg DM; Blumenthal RD
Clin Cancer Res; 2002 Apr; 8(4):1213-22. PubMed ID: 11948135
[TBL] [Abstract][Full Text] [Related]
33. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
[TBL] [Abstract][Full Text] [Related]
34. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.
Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M
J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression.
Heil M; Clauss M; Suzuki K; Buschmann IR; Willuweit A; Fischer S; Schaper W
Eur J Cell Biol; 2000 Nov; 79(11):850-7. PubMed ID: 11139149
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
Ohno-Matsui K; Yoshida T; Uetama T; Mochizuki M; Morita I
Biochem Biophys Res Commun; 2003 Apr; 303(3):962-7. PubMed ID: 12670505
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.
Fitzpatrick TE; Lash GE; Yanaihara A; Charnock-Jones DS; Macdonald-Goodfellow SK; Graham CH
Exp Cell Res; 2003 Feb; 283(2):247-55. PubMed ID: 12581744
[TBL] [Abstract][Full Text] [Related]
38. VEGF-A-induced chemotaxis of CD16+ monocytes is decreased secondary to lower VEGFR-1 expression.
Czepluch FS; Olieslagers S; van Hulten R; Vöö SA; Waltenberger J
Atherosclerosis; 2011 Apr; 215(2):331-8. PubMed ID: 21324460
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.
Hiratsuka S; Maru Y; Okada A; Seiki M; Noda T; Shibuya M
Cancer Res; 2001 Feb; 61(3):1207-13. PubMed ID: 11221852
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
